BHVN FY2025 SEC EDGAR DEF 14A #113 of 168 in industry

Biohaven Ltd. CEO pay ratio

The CEO earned $529K in FY2025 against median worker pay of $529,257 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
D8
Filing date
2026-03-13
Industry
Chemicals & Pharmaceuticals
Industry rank
#113/168

Data updated August 2026

Subscribe to Biohaven Ltd. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
25:1
Below Average (Scale: 0–1000:1)
CEO pay
$529K
Median worker
$529,257

Answer first

Biohaven Ltd.'s FY2025 CEO total of $529K ranks #1279 of 1,423 complete filings; its 25:1 pay ratio ranks #1171. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $529,257. Industry placement uses the FY2025 SIC-28 peer cohort (# 113 of 168, 33rd percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1279
$529K of 1,423 FY2025
Ratio rank
#1171
25:1 of 1,423
Industry pct
33rd
below the industry median pay ratio

How Biohaven Ltd. ranks nationally

Biohaven Ltd. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$529,257 10th percentile higher than 10% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Biohaven Ltd. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($529K) against pay ratio (25:1) for Biohaven Ltd. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both33658.62759449.65485240.58211031.410936822.323.1:128.1:133:138.0:142.9:1CEO total payPay ratio (CEO : median worker)Biohaven Ltd., CEO total pay: 529257 · Pay ratio (CEO : median worker): 25:1Biohaven Ltd.Siga Technologies Inc, CEO total pay: 3202425 · Pay ratio (CEO : median worker): 25:1Siga Technologies IncArdelyx, Inc., CEO total pay: 7796171 · Pay ratio (CEO : median worker): 25:1Ardelyx, Inc.Sarepta Therapeutics, Inc., CEO total pay: 7708375 · Pay ratio (CEO : median worker): 25:1Sarepta Therapeutics, Inc.Vir Biotechnology, Inc., CEO total pay: 7948488 · Pay ratio (CEO : median worker): 24:1Vir Biotechnology, Inc.Mirum Pharmaceuticals, Inc., CEO total pay: 10441224 · Pay ratio (CEO : median worker): 24:1Mirum Pharmaceuticals, Inc.
Biohaven Ltd. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Biohaven Ltd.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Biohaven Ltd.

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
25:1
FY2025
vs prior FY
0:1
from FY2024 25:1
CEO $ YoY
+30%
$529K latest
Filings shown
2
FY2024–2025
Biohaven Ltd. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $408K - $408,248 25:1 -
2025 $529K +30% $529,257 25:1 0:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1935979, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
25:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$529K
Companies in Industry
168
vs. Industry Median
Below
#113 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Biohaven Ltd.: MODEST · LIGHT pay ratio

Biohaven Ltd.'s FY2025 CEO total $529K ranks #1279 of 1,423 complete filings (lower third by dollars). the CEO earned 25× the median employee ($529,257) in FY2025.

Median employee $529,257 (ELITE-MED); MODEST · LIGHT stamps put about 25 median-wage years per CEO year.

CEO Total Pay

$529K

FY2025 Summary Compensation, below median

Pay Ratio

25:1

Below typical

Biohaven Ltd. in the lower-dollar third

Biohaven Ltd.'s FY2025 CEO total $529K ranks #1279 of 1,423 complete filings (lower third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Biohaven Ltd.'s $529K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1279 and ratio rank #1171 split - treat 25:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$529K
Median Employee Pay
$529,257
Pay Ratio
25:1
Filing Date
2026-03-13

Company Info

Ticker
BHVN
CIK
1935979
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
D8
View SEC filings →
SEC EDGAR DEF 14A for CIK 1935979, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Biohaven Ltd.'s FY2025 CEO total $529K ranks #1279 of 1,423 complete filings (lower third by dollars).

Read with Biohaven Ltd.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · LIGHT · ELITE-MED.

Nuvalent, Inc. · LIGHT

ABS(ceo_total_comp) peer at $540K (Δ $11K heavier vs Biohaven Ltd.); FLOOR · ELITE-MED vs this page's MODEST · LIGHT · ELITE-MED.
Tetra Technologies Inc · LIGHT

ABS(ceo_total_comp) peer at $508K (Δ $21K lighter vs Biohaven Ltd.); FLOOR · HIGH-MED vs this page's MODEST · LIGHT · ELITE-MED.
Dorchester Minerals, L.P. · LIGHT

ABS(ceo_total_comp) peer at $563K (Δ $34K heavier vs Biohaven Ltd.); FLOOR · ELITE-MED vs this page's MODEST · LIGHT · ELITE-MED.
Octave Specialty Group Inc · LIGHT

ABS(ceo_total_comp) peer at $567K (Δ $38K heavier vs Biohaven Ltd.); FLOOR · HIGH-MED vs this page's MODEST · LIGHT · ELITE-MED.
Siga Technologies Inc (SIC 28 pole)

Siga Technologies Inc stamps MODEST · MID$ nearest in-SIC by ABS(pay_ratio) to Biohaven Ltd.'s MODEST filing.
National dual ranks · #1279/#1171

Biohaven Ltd.'s FY2025 package sits #1279 by CEO dollars and #1171 by ratio under LIGHT · MODEST.
Ratio primer · MODEST

Biohaven Ltd.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Biohaven Ltd. (CIK 1935979), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.